America's Best Nonprofits
  1. Home
  2. Public Benefit
  3. Washington, DC
  4. Doctors for Cannabis Regulation

Doctors for Cannabis Regulation

  • Washington, DC
  • Tax-exempt since 2016
  • EIN: 47-5335200
d4dpr.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate

Organization summary

Doctors for Cannabis Regulation is a 501(c)(3) organization, classified under Public Benefit (NTEE W99). Contributions are tax-deductible.

712 H Street Ne Suite 1290, Washington, DC 20002-3627

In fiscal year 2025 it reported $78,082 in revenue and $27,946 in expenses, with contributions making up 100.0% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Description;Amount^Website and software services;1130|Conference supplies and expenses;954|Fundraising;261|Delaware annual fee;25|Professional liability insurance;1500|Statutory representation;155|Professional committees;40|Administrating restricted grants;1093^Total;5158^

Largest programs · fiscal year 2025

  • Expansion of Mission and Public Health Scope During the reporting period, D4DPR continued its transition from a cannabis-focused organization to a broader public health-oriented organization addressing drug policy across all illegal drugs. This expansion enabled the organization to engage a wider range of physicians, scientists, and health professionals; address emerging and complex drug-related p… Read more

    Expansion of Mission and Public Health Scope During the reporting period, D4DPR continued its transition from a cannabis-focused organization to a broader public health-oriented organization addressing drug policy across all illegal drugs. This expansion enabled the organization to engage a wider range of physicians, scientists, and health professionals; address emerging and complex drug-related public health issues; and contribute to national and international discussions on evidence-based, health-centered drug policy. This work supports the organization's charitable purpose by reducing stigma, improving public understanding, and promoting policies that enhance health outcomes.

    $226 spent · 1.2% of program spending
  • Advancement of Evidence-Based Regulatory Standards D4DPR's work in developing standardized cannabis labeling and warnings continued to influence state-level regulatory frameworks. The International Intoxication Cannabinoid Product Symbol (IICPS), developed with D4DPR involvement, has been adopted in multiple states and is under consideration in additional jurisdictions. Standardized warning langua… Read more

    Advancement of Evidence-Based Regulatory Standards D4DPR's work in developing standardized cannabis labeling and warnings continued to influence state-level regulatory frameworks. The International Intoxication Cannabinoid Product Symbol (IICPS), developed with D4DPR involvement, has been adopted in multiple states and is under consideration in additional jurisdictions. Standardized warning language developed by D4DPR has also been adopted at the state level. These efforts contribute to improved consumer awareness, product safety, and consistency in public health messaging.

    $226 spent · 1.2% of program spending
  • Education and Dissemination of Scientific and Policy Information D4DPR provided education to healthcare professionals, policymakers, and the public through webinars, written publications, and media engagement. Educational topics included hemp-derived cannabinoids, international drug policy, psychedelics, overdose prevention strategies, and treatment for substance use disorders. The organization pr… Read more

    Education and Dissemination of Scientific and Policy Information D4DPR provided education to healthcare professionals, policymakers, and the public through webinars, written publications, and media engagement. Educational topics included hemp-derived cannabinoids, international drug policy, psychedelics, overdose prevention strategies, and treatment for substance use disorders. The organization produced and disseminated position papers and policy analyses addressing cannabis scheduling, overdose prevention centers, and related issues. Outreach activities included webinars, op-eds, letters to the editor, and media appearances, expanding access to evidence-based information and supporting informed decision-making.

    $2,495 spent · 13.0% of program spending
  • Development of the Health Advocacy Toolkit With grant support, D4DPR developed a comprehensive Health Advocacy Toolkit designed to train healthcare professionals in effective, evidence-based public health advocacy. The toolkit includes policy briefs, fact sheets, and instructional modules on engaging with legislative and regulatory processes, preparing written and oral testimony, and communicating… Read more

    Development of the Health Advocacy Toolkit With grant support, D4DPR developed a comprehensive Health Advocacy Toolkit designed to train healthcare professionals in effective, evidence-based public health advocacy. The toolkit includes policy briefs, fact sheets, and instructional modules on engaging with legislative and regulatory processes, preparing written and oral testimony, and communicating scientific information to policymakers. This initiative increases the capacity of clinicians to participate in public health policy discussions and promotes the dissemination of accurate, science-based information.

    $15,857 spent · 82.7% of program spending
  • D4DPR launched Physicians for Opioid Settlement Equity (POSE), an initiative aimed at promoting the equitable and evidence-based allocation of opioid settlement funds. This initiative is focused on New York and New Jersey. POSE engages physicians and other healthcare professionals to educate policymakers and the public on effective uses of settlement funds, including treatment access, harm reducti… Read more

    D4DPR launched Physicians for Opioid Settlement Equity (POSE), an initiative aimed at promoting the equitable and evidence-based allocation of opioid settlement funds. This initiative is focused on New York and New Jersey. POSE engages physicians and other healthcare professionals to educate policymakers and the public on effective uses of settlement funds, including treatment access, harm reduction services, and prevention strategies. This initiative advances public health by supporting the allocation of resources toward interventions with demonstrated effectiveness in reducing overdose and improving outcomes for individuals with substance use disorders.

    $113 spent · 0.6% of program spending

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$78,082Fiscal year 20252022: $25,03420222023: $17,29120232025: $78,0822025
Expenses$27,946Fiscal year 20252022: $20,22920222023: $25,87620232025: $27,9462025
Total assets—Fiscal year 20252022: $11,5002022
Total liabilities—Fiscal year 20252022: $15,0002022
Fiscal year ending December 2025
Revenue$78,082
Expenses$27,946
Net income$50,136
Net assets$52,833

Notable sources of revenue

Percent of total revenue
Contributions$78,082
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets—
Total liabilities—
Net assets$52,833

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$17,291
Expenses$25,876
Net income−$8,585
Net assets−$12,085

Notable sources of revenue

Percent of total revenue
Contributions$17,291
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets—
Total liabilities—
Net assets−$12,085

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$25,034
Expenses$20,229
Net income$4,805
Net assets−$3,500

Notable sources of revenue

Percent of total revenue
Contributions$25,034
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets$11,500
Total liabilities$15,000
Net assets−$3,500

Compensation

Not in our extract for this year.

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?